Carbiotix
Carbiotix AB announces the outcome of the exercise of warrants of series TO 2
During the exercise period from and including October 12, 2023, up to and including October 26, 2023, holders of warrants of series TO 2 have had the right to subscribe for one (1) new share in Carbiotix for each warrant of series TO 2 at a price of SEK1.50 per share. No warrants have been exercised and thus no share capital increase or change in the number of shares in the Company has taken place. The number of shares is thus still 20,736,229 and the share capital is SEK 2,073,622.90.
For more information about the warrants, please contact:
Sedermera Corporate Finance AB
Tel: +46 (0)40 615 14 10
E-mail: cf@sedermera.se
www.sedermera.se
For more information, please contact:
Erik Deaner, VD
Telefon: +46 (0)73-867 30 85
E-post: erik.deaner@carbiotix.com
About Carbiotix
Carbiotix AB (CRBX) (www.carbiotix.com) is an award-winning biotechnology company pioneering microbiome health through a portfolio of prebiotic modulators and diagnostic testing services.
| Datum | 2023-10-27, kl 11:00 |
| Källa | Cision |
SAVR är investeringsplattformen som utmanar branschen och gör det både enklare och roligare att investera. Betala aldrig för mycket! Alla aktier och ETF:er från 1 kr, och få upp till 50 % rabatt på alla fonder. Automatiskt courtage och samma enkla prismodell på alla marknader.